Tyrosine Kinase Inhibitors Market: Exploring the Future of Precision Oncology
The global tyrosine kinase inhibitors (TKIs) market is witnessing significant developments, driven by the increasing prevalence of cancer, rising healthcare expenditure, and growing demand for targeted cancer therapies. The market was valued at more than US$ 18.0 billion in 2017 and was projected to surpass US$ 19.0 billion by 2026. Although the market faced a negative compound annual growth...
0 Kommentare 0 Geteilt 70 Ansichten 0 Bewertungen
Urh Social https://urh.app